Activated T lymphocytes within human solid tumors

[1]  J. Stjernswärd,et al.  Human tumor — Lymphocyte interaction in vitro , 1978, Cancer Immunology, Immunotherapy.

[2]  U. Galili,et al.  Regulation of the cytotoxic effect of human ‘normal killer cells’ on tumor cell lines by neuraminidase-treated T-lymphocytes , 1978, Cancer Immunology, Immunotherapy.

[3]  M. Hanna,et al.  In Situ Expression of Tumor Immunity , 1980, Contemporary topics in immunobiology.

[4]  E. Klein,et al.  Natural species-restricted attachment of human and murine T lymphocytes to various cells. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[5]  L. Andersson,et al.  Accumulation of thyroid antigen-reactive T lymphocytes in the gland of patients with subacute thyroiditis. , 1978, Clinical and experimental immunology.

[6]  L. Sköldstam,et al.  B- and T-lymphocytes in toxic diffuse goitre. , 1978, Clinical and experimental immunology.

[7]  E. Klein,et al.  Human tumour—lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour‐infiltrating, blood and lymph‐node lymphocytes with autologous tumour cells , 1977, International Journal of Cancer.

[8]  David W. Hughes,et al.  The inconstant Sun , 1977, Nature.

[9]  S. Russell,et al.  Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of moloney sarcoma regression or progression , 1976, International journal of cancer.

[10]  H. Ioachim.  The stromal reaction of tumors: an expression of immune surveillance. , 1976, Journal of the National Cancer Institute.

[11]  U. Galili,et al.  The formation of stable E-rosettes by human T lymphocytes activated in mixed lymphocyte reactions. , 1976, Journal of immunology.

[12]  H. Kirchner,et al.  Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors. , 1976, Journal of immunology.

[13]  G. Berke.  Lymphocyte-target cell conjugation: membrane receptors for alloantigens. , 1976, Advances in experimental medicine and biology.

[14]  J. Haskill,et al.  Host responses within solid tumors: Non‐thymus‐derived specific cytotoxic cells within a murine mammary adenocarcinoma , 1975, International journal of cancer.

[15]  J. Natvig,et al.  Elution and Characterization of Lymphocytes from Rheumatoid Inflammatory Tissue , 1975 .

[16]  J. Natvig,et al.  Elution and Characterization of Lymphocytes from Rheumatoid Inflammatory Tissue , 1975, Scandinavian journal of immunology.

[17]  G. Klein,et al.  Classification of lymphocytes in nasopharyngeal carcinoma (NPC) biopsies. , 1975, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

[18]  E. Klein,et al.  Killer T cells in a Burkitt's lymphoma biopsy , 1975, Nature.

[19]  C. Lozzio,et al.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. , 1975, Blood.

[20]  A. Bertolotti,et al.  Host Resistance in Relation to Survival in Breast Cancer , 1974, British medical journal.

[21]  S. Paglin,et al.  Morphologic evidence suggestive of host-tumor cell interactions in vivo in human cancer patients. , 1974, Journal of the National Cancer Institute.

[22]  K. Bagshawe,et al.  Cellular Reaction in Trophoblastic Tumours , 1973, British Journal of Cancer.

[23]  J. Natvig,et al.  Immunological Characterization of Lymphocytes in Synovial Fluid from Patients with Rheumatoid Arthritis , 1973, Scandinavian journal of immunology.

[24]  E. Shevach,et al.  Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines. , 1972, The Journal of clinical investigation.

[25]  George,et al.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. , 1968, Cancer research.